製品名:6,7-Dihydro-2H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3(5H)-one

IUPAC Name:3,4-diazatricyclo[9.4.0.0²,⁷]pentadeca-1(15),2,6,11,13-pentaen-5-one

CAS番号:25823-52-3
分子式:C13H12N2O
純度:95%
カタログ番号:CM324062
分子量:212.25

包装単位 有効在庫 価格(USD) 数量
CM324062-250mg in stock NJŴƦ
CM324062-1g 1-2 Weeks ƀțƦ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:25823-52-3
分子式:C13H12N2O
融点:-
SMILESコード:O=C1C=C(CCCC2=CC=CC=C23)C3=NN1
密度:
カタログ番号:CM324062
分子量:212.25
沸点:
MDL番号:MFCD16871353
保管方法:

Column Infos

Bemcentinib
Bemcentinib is a potentially first-in-class selective AXL inhibitor in development for STK11 mutated NSCLC and severe respiratory infections. Extensive studies confirm the ability to combine bemcentinib with immune checkpoint inhibitors, chemotherapies and targeted therapies with the goal of improving a patient’s immune response and delaying the development of chemoresistance. Bemcentinib is currently being investigated in combination with immune checkpoint inhibition and chemotherapy in first line NSCLC patients harboring mutations in the STK11 gene, a known prognostic factor of poor response to existing therapies.

Related Products